Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
12.5M
-
Shares change
-
-353K
-
Total reported value, excl. options
-
$73.7M
-
Value change
-
-$2.04M
-
Number of buys
-
20
-
Number of sells
-
-21
-
Price
-
$5.90
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q2 2025
55 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q2 2025.
Profound Medical Corp. - Common Shares (PROF) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.5M shares
of 29.9M outstanding shares and own 41.77% of the company stock.
Largest 10 shareholders include FIL Ltd (1.89M shares), GAGNON SECURITIES LLC (1.75M shares), LETKO, BROSSEAU & ASSOCIATES INC (1.2M shares), RAYMOND JAMES FINANCIAL INC (942K shares), Gagnon Advisors, LLC (897K shares), Timelo Investment Management Inc. (841K shares), ROYCE & ASSOCIATES LP (765K shares), Rosalind Advisors, Inc. (692K shares), MMCAP International Inc. SPC (491K shares), and Royal Bank of Canada (460K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.